European Network of Excellence for Big Data in Hematology. Funded by the Innovative Medicines Initiative. Read more
Registration of novel drug compounds is increasingly difficult, costly, and time-consuming, thus preventing patients from receiving the right treatment in time. Patients with hematologic malignancies (HMs) have unmet needs that must be addressed. Read more
53 Partners sharing the same goal: use ‘big data’ technologies to deliver information that will help to improve the care of patients with hematological malignancies: Introducing the HARMONY Alliance. Read more
Europe's largest public-private partnership aiming to improve the outcomes of patients with hematological malignancies through the use of big data sharing among all relevant stakeholders involved.
Big Data has been attributed as having “transformative potential” in healthcare systems, with benefits across the entire pathway of care delivery for all stakeholders.Read more